For the quarter ending 2026-03-31, HALO has $2,672,719K in assets. $2,453,083K in debts. $309,749K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 309,749 | 133,820 | 419,665 | 61,861 |
| Marketable securities, available-for-sale | 8,873 | 9,000 | 282,298 | 486,316 |
| Accounts receivable, net and contract assets | 457,989 | 441,273 | 346,035 | 316,339 |
| Inventories | 155,467 | 176,475 | 185,796 | 181,505 |
| Prepaid expenses and other current assets | 70,958 | 64,639 | 94,955 | 76,652 |
| Total current assets | 1,003,036 | 825,207 | 1,328,749 | 1,122,673 |
| Property and equipment, gross | 82,149 | 77,601 | 71,634 | - |
| Accumulated depreciation and amortization | 35,215 | 33,159 | 31,059 | - |
| Subtotal | 46,934 | 44,442 | 40,575 | - |
| Right of use of assets | 35,296 | 37,695 | 30,845 | - |
| Property and equipment, net | 82,230 | 82,137 | 71,420 | 71,520 |
| Prepaid expenses and other assets | 50,915 | 53,551 | 55,698 | 56,371 |
| Goodwill | 582,323 | 580,360 | 416,821 | 416,821 |
| Gross carrying value | - | - | 538,200 | - |
| Accumulated amortization | - | - | 238,356 | - |
| Total | - | - | 299,844 | - |
| Atrs-1902 (ipr&d) | - | - | 48,700 | - |
| Intangible assets, net | 951,955 | 981,467 | 348,544 | 366,306 |
| Deferred tax assets, net | - | 0 | 0 | 20,208 |
| Restricted cash | 2,260 | 2,601 | - | - |
| Total assets | 2,672,719 | 2,525,323 | 2,221,232 | 2,053,899 |
| Accounts payable | 14,098 | 20,899 | 15,360 | 18,691 |
| Accrued expenses | 140,369 | 156,193 | 111,183 | 115,591 |
| Current portion of long-term debt, net | 208,743 | - | 710,685 | - |
| Total current liabilities | 363,210 | 177,092 | 837,228 | 134,282 |
| Long-term debt, net | 1,935,896 | 2,142,630 | 800,072 | 1,509,100 |
| Other long-term liabilities | 106,448 | 113,863 | 71,799 | 77,769 |
| Deferred tax liabilities, net | 47,529 | 42,924 | 8,218 | - |
| Total liabilities | 2,453,083 | 2,476,509 | 1,717,317 | 1,721,151 |
| Common stock - 0.001 par value 300,000 shares authorized 118,523 and 117,782 shares issued and outstanding as of march31, 2026 and december31, 2025, respectively | 118 | 118 | 118 | 118 |
| Additional paid-in capital | 27,386 | 12,002 | 23,909 | 0 |
| Accumulated other comprehensive loss | -12,703 | -18,092 | -22,258 | -28,403 |
| Retained earnings | 204,835 | 54,786 | 502,146 | 361,033 |
| Total stockholders equity | 219,636 | 48,814 | 503,915 | 332,748 |
| Total liabilities and stockholders equity | 2,672,719 | 2,525,323 | 2,221,232 | 2,053,899 |
HALOZYME THERAPEUTICS, INC. (HALO)
HALOZYME THERAPEUTICS, INC. (HALO)